1. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol (1999) 17(5):1442-8. Epub 1999/05/20. doi: 10.1200/jco.1999.17.5.1442. PubMed PMID: 10334529.
2. The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization. American journal of clinical pathology (1982) 78(6):806-16. Epub 1982/12/01. doi: 10.1093/ajcp/78.6.806. PubMed PMID: 7148748.
3. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat (2008) 111(3):541-7. Epub 2007/11/21. doi: 10.1007/s10549-007-9809-z. PubMed PMID: 18026874.
4. Lei L, Yu X, Chen B, Chen Z, Wang X. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study. Plos One (2016) 11(5). doi: 10.1371/journal.pone.0155132. PubMed PMID: WOS:000376883000002.
5. Lacroix-Triki M, Suarez PH, MacKay A, Lambros MB, Natrajan R, Savage K, et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. The Journal of pathology (2010) 222(3):282-98. Epub 2010/09/04. doi: 10.1002/path.2763. PubMed PMID: 20815046.
6. Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. Journal of breast cancer (2011) 14(4):308-13. Epub 2012/02/11. doi: 10.4048/jbc.2011.14.4.308. PubMed PMID: 22323918; PubMed Central PMCID: PMCPMC3268928.
7. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. International journal of radiation oncology, biology, physics (2004) 59(1):152-9. Epub 2004/04/20. doi: 10.1016/j.ijrobp.2003.10.029. PubMed PMID: 15093911.
8. Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2006) 15(10):1899-905. Epub 2006/10/13. doi: 10.1158/1055-9965.epi-06-0191. PubMed PMID: 17035397.
9. Skotnicki P, Sas-Korczynska B, Strzepek L, Jakubowicz J, Blecharz P, Reinfuss M, et al. Pure and Mixed Mucinous Carcinoma of t: A Comparison of Clinical Outcomes and Treatment Resultshe Breast. Breast Journal (2016) 22(5):529-34. doi: 10.1111/tbj.12621. PubMed PMID: WOS:000383520200006.
10. Wasif N, McCullough AE, Gray RJ, Pockaj BA. Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique? Journal of Surgical Oncology (2012) 105(6):586-90. doi: 10.1002/jso.22132. PubMed PMID: WOS:000302550200012.
11. Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, et al. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Annals of surgical oncology (2012) 19(9):3019-27. Epub 2012/03/28. doi: 10.1245/s10434-012-2322-6. PubMed PMID: 22451233.
12. Louwman MW, Vriezen M, van Beek MW, Nolthenius-Puylaert MC, van der Sangen MJ, Roumen RM, et al. Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. International journal of cancer (2007) 121(1):127-35. Epub 2007/03/03. doi: 10.1002/ijc.22625. PubMed PMID: 17330844.
13. Fu J, Wu L, Jiang M, Li D, Jiang T, Hong Z, et al. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer. Plos One (2016) 11(10). doi: 10.1371/journal.pone.0164921. PubMed PMID: WOS:000386204000065.
14. Ishikawa T, Hamaguchi Y, Ichikawa Y, Shimura M, Kawano N, Nakatani Y, et al. Locally advanced mucinous carcinoma of the breast with sudden growth acceleration: a case report. Japanese journal of clinical oncology (2002) 32(2):64-7. Epub 2002/04/12. doi: 10.1093/jjco/hyf012. PubMed PMID: 11948231.
15. Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast Cancer Research and Treatment (2002) 76(3):255-60. doi: 10.1023/a:1020808020873. PubMed PMID: WOS:000178929800008.
16. Pareja F, Lee JY, Brown DN, Piscuoglio S, Gularte-Merida R, Selenica P, et al. The Genomic Landscape of Mucinous Breast Cancer. Journal of the National Cancer Institute (2019). doi: 10.1093/jnci/djy216. PubMed PMID: MEDLINE:30649385.
17. Rasmussen BB, Rose C, Christensen IB. Prognostic factors in primary mucinous breast carcinoma. American journal of clinical pathology (1987) 87(2):155-60. Epub 1987/02/01. doi: 10.1093/ajcp/87.2.155. PubMed PMID: 3028120.
18. Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Annals of surgical oncology (1998) 5(5):447-51. Epub 1998/08/26. PubMed PMID: 9718175.
19. Gwark SC, Lee HS, Lee Y, Lee SB, Sohn G, Kim J, et al. Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer. Annals of surgical oncology (2019) 26(7):2166-74. Epub 2019/04/13. doi: 10.1245/s10434-019-07332-9. PubMed PMID: 30977015.
20. Ding S, Wu J, Lin C, Chen W, Li Y, Shen K, et al. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With PureMucinous Breast Cancer: A SEER Population-Based Retrospective Analysis. Clinical breast cancer (2018). doi: 10.1016/j.clbc.2018.10.001. PubMed PMID: MEDLINE:30396812.
21. Wu SG, Li FY, Wang J, Lian CL, Zhou J, He ZY. Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma. Radiation oncology (London, England) (2019) 14(1):190. Epub 2019/11/07. doi: 10.1186/s13014-019-1394-x. PubMed PMID: 31685005; PubMed Central PMCID: PMCPMC6829954.
22. National Cancer Institute: Surveillance, Epidemiology, and End Results. Available from: https://seer.cancer.gov/.
23. Iwamoto T, Booser D, Valero V, Murray JL, Koenig K, Esteva FJ, et al. Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry. J Clin Oncol (2012) 30(7):729-34. Epub 2012/02/01. doi: 10.1200/jco.2011.36.2574. PubMed PMID: 22291085.
24. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 28(16):2784-95. Epub 2010/04/21. doi: 10.1200/jco.2009.25.6529. PubMed PMID: 20404251; PubMed Central PMCID: PMCPMC2881855.
25. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England) (2005) 366(9503):2087-106. Epub 2005/12/20. doi: 10.1016/s0140-6736(05)67887-7. PubMed PMID: 16360786.
26. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London, England) (2011) 378(9804):1707-16. Epub 2011/10/25. doi: 10.1016/s0140-6736(11)61629-2. PubMed PMID: 22019144; PubMed Central PMCID: PMCPMC3254252.
27. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 17(8):2326-33. Epub 1999/11/24. doi: 10.1200/jco.1999.17.8.2326. PubMed PMID: 10561294.
28. Pan B, Yao R, Shi J, Xu Q-Q, Zhou Y-D, Mao F, et al. Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014). Oncotarget (2016) 7(25):38864-75. doi: 10.18632/oncotarget.8778. PubMed PMID: WOS:000378229100116.
29. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg (2007) 194(4):527-31. Epub 2007/09/11. doi: 10.1016/j.amjsurg.2007.06.012. PubMed PMID: 17826073.
30. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. The Lancet Oncology (2010) 11(3):231-40. Epub 2010/02/09. doi: 10.1016/s1470-2045(09)70382-1. PubMed PMID: 20138809.
31. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. The New England journal of medicine (2013) 368(11):987-98. Epub 2013/03/15. doi: 10.1056/NEJMoa1209825. PubMed PMID: 23484825.
32. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. The Lancet Oncology (2013) 14(11):1086-94. Epub 2013/09/24. doi: 10.1016/s1470-2045(13)70386-3. PubMed PMID: 24055415.
33. Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2015) 114(1):56-65. Epub 2014/12/03. doi: 10.1016/j.radonc.2014.10.004. PubMed PMID: 25454172.
34. Walker GV, Giordano SH, Williams M, Jiang J, Niu J, MacKinnon J, et al. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. International journal of radiation oncology, biology, physics (2013) 86(4):686-93. Epub 2013/06/19. doi: 10.1016/j.ijrobp.2013.03.016. PubMed PMID: 23773392; PubMed Central PMCID: PMCPMC3836610.